Extended release injectable Buprenorphine
Showing 1 - 25 of 8,303
Opioid-Use Disorder, Opioid Overdose Trial in Vancouver
Recruiting
- Opioid-Use Disorder
- Opioid Overdose
-
Vancouver, British Columbia, CanadaRapid Access Addiction Clinic (RAAC), St. Paul's Hospital
Nov 16, 2022
Cocaine Use Disorder Trial (Extended-Release Naltrexone, Extended Release Buprenorphine, Placebo (PLB) Injectable)
Not yet recruiting
- Cocaine Use Disorder
- Extended-Release Naltrexone
- +2 more
- (no location specified)
Jul 15, 2022
Opioid-Related Disorders, Substance-Related Disorders, Narcotic-Related Disorders Trial in United States (Injectable
Not yet recruiting
- Opioid-Related Disorders
- +2 more
- Injectable extended-release buprenorphine
- Sublingual buprenorphine-naloxone
-
Garberville, California
- +5 more
Aug 28, 2023
Human Immunodeficiency Virus, Opioid Use Disorder Trial in Providence (Combined LAI Treatment: Cabenuva and Sublocade)
Recruiting
- Human Immunodeficiency Virus
- Opioid Use Disorder
- Combined LAI Treatment: Cabenuva and Sublocade
-
Providence, Rhode IslandRhode Island Hospital
Aug 7, 2023
Opiate Substitution Treatment Trial in United Kingdom (Buprenorphine Injectable Product, Methadone, Buprenorphine)
Active, not recruiting
- Opiate Substitution Treatment
- Buprenorphine Injectable Product
- +2 more
-
Birmingham, United Kingdom
- +4 more
Feb 21, 2022
Opioid Use Disorder Trial in New York (Extended-Release Buprenorphine (XRB), Sublingual Buprenorphine (SLB))
Not yet recruiting
- Opioid Use Disorder
- Extended-Release Buprenorphine (XRB)
- Sublingual Buprenorphine (SLB)
-
New York, New YorkNYU Langone Health - 180 Madison Ave
Sep 18, 2023
Cocaine Dependence Trial in United States (Buprenorphine + Naltrexone, Placebo + Naltrexone)
Completed
- Cocaine Dependence
- Buprenorphine + Naltrexone
- Placebo + Naltrexone
-
Los Angeles, California
- +10 more
Oct 1, 2021
Opioid-use Disorder Trial in New York (extended-release buprenorphine (BXR), sublingual buprenorphine (BSL))
Recruiting
- Opioid-use Disorder
- extended-release buprenorphine (BXR)
- sublingual buprenorphine (BSL)
-
New York, New YorkNyspi-Stars
Sep 29, 2022
Opioid Use Disorder Trial (Buprenorphine Extended-Release Injection)
Not yet recruiting
- Opioid Use Disorder
- Buprenorphine Extended-Release Injection
- (no location specified)
Feb 2, 2023
Opioid Use Disorder Trial in New York (Extended-Release Buprenorphine Injection)
Not yet recruiting
- Opioid Use Disorder
- Extended-Release Buprenorphine Injection
-
New York, New YorkNYU Langone Health
Jul 28, 2022
Opioid Dependence Trial in New York (Buprenorphine Extended Release, Sublingual Buprenorphine (SUBOXONE, Zubsolv, or generic
Completed
- Opioid Dependence
- Buprenorphine Extended Release
- Sublingual Buprenorphine (SUBOXONE, Zubsolv, or generic tablets)
-
New York, New YorkBellevue Hospital Center
Dec 13, 2021
Substance Use Disorder, Opioid Use Disorder, Moderate, Opioid Use Disorder, Severe Trial in United States (Extended Release
Recruiting
- Substance Use Disorder
- +2 more
- Extended Release Buprenorphine
- Treatment as Usual
-
New Haven, Connecticut
- +4 more
Dec 21, 2022
Moderate to Severe Opioid Use Disorder Trial in Canada (Extended Release Subcutaneous Buprenorphine, Immediate Release
Not yet recruiting
- Moderate to Severe Opioid Use Disorder
- Extended Release Subcutaneous Buprenorphine
- Immediate Release Sublingual Buprenorphine
-
Barrie, Ontario, Canada
- +4 more
Oct 20, 2022
Opioid-use Disorder, Opioid Withdrawal Trial in Rancho Mirage, Baltimore, Center City (Sparrow Ascent Therapy System,
Recruiting
- Opioid-use Disorder
- Opioid Withdrawal
- Sparrow Ascent Therapy System
- +2 more
-
Rancho Mirage, California
- +2 more
Jun 9, 2022
Drug Dependence Trial in Baltimore (Extended Release Naltrexone, Psychosocial Treatment, Buprenorphine)
Completed
- Drug Dependence
- Extended Release Naltrexone
- +2 more
-
Baltimore, Maryland
- +1 more
Oct 13, 2021
Heroin Dependence, Opioid Dependence Trial in Philadelphia (Naltrexone)
Completed
- Heroin Dependence
- Opioid Dependence
-
Philadelphia, PennsylvaniaCenter for the Studies of Addiction
Feb 11, 2022
Opioid-Related Disorders, Drug Addiction, Pregnancy Related Trial in United States (Buprenorphine Injection, Buprenorphine
Recruiting
- Opioid-Related Disorders
- +7 more
- Buprenorphine Injection
- Buprenorphine Sublingual Product
-
San Francisco, California
- +12 more
Feb 10, 2022
Opioid Use Disorder Trial in Philadelphia (Buprenorphine injection, Naltrexone Injection)
Recruiting
- Opioid Use Disorder
- Buprenorphine injection
- Naltrexone Injection
-
Philadelphia, PennsylvaniaAddiction Treatment Center, University of Pennsylvania
Feb 1, 2023
Alcohol Use Disorder, Alcoholism Trial in Philadelphia (XR-NTX 380 mg, intramuscular injection, Medical Management, Placebo
Recruiting
- Alcohol Use Disorder
- Alcoholism
- XR-NTX 380 mg, intramuscular injection
- +2 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania Center for Studies of Addiction
Jun 6, 2022
Opioid-Related Disorders, Drug Addiction, Pregnancy Related Trial in United States (Buprenorphine Injection, Buprenorphine
Recruiting
- Opioid-Related Disorders
- +7 more
- Buprenorphine Injection
- Buprenorphine Sublingual Product
-
San Francisco, California
- +12 more
Feb 10, 2022
Pain, Postoperative Trial in Taipei city (Marcaine® 100mg/20mL (0.5%) bupivacaine solution for Injection, ND-340 (Bupivacaine
Recruiting
- Pain, Postoperative
- Marcaine® 100mg/20mL (0.5%) bupivacaine solution for Injection
- ND-340 (Bupivacaine Microsphere), 300 mg/vial bupivacaine for extended-release injectable suspension
-
Taipei city, TaiwanNational Taiwan University Hospital
Oct 18, 2022
Pain, Postoperative Trial in Philadelphia (Zynrelef (Bupivacaine 60 MG / Meloxicam 1.8 MG) Per 2.3 ML Extended Release Solution,
Enrolling by invitation
- Pain, Postoperative
- Zynrelef (Bupivacaine 60 MG / Meloxicam 1.8 MG) Per 2.3 ML Extended Release Solution
- +2 more
-
Philadelphia, PennsylvaniaRothman Orthopaedic Institute
Mar 1, 2023